Savai et al. [26] reported that FoxO1 in pulmonary artery smooth muscle cells (PASMCs) are a critical integrator of multiple signaling pathways driving pulmonary hypertension (PH), and reconstitution of FoxO1 activity offers a potential therapeutic option for PH. Here, FOXO1 is linked to pulmonary arterial hypertension.